Dantrium (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Dantrium drug offered from Par Pharmaceutical, Inc.. This Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | dantrolene sodium |
| SUBSTANCE NAME: | DANTROLENE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-04-20 |
| END MARKETING DATE: | 0000-00-00 |
Dantrium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dantrium from Par Pharmaceutical, Inc. |
| LABELER NAME: | Par Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/60mL) |
| START MARKETING DATE: | 2009-04-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42023-123_44e02603-a1bb-439b-9b74-aa90bab5f472 |
| PRODUCT NDC: | 42023-123 |
| APPLICATION NUMBER: | NDA018264 |
Other DANTROLENE SODIUM Pharmaceutical Manufacturers / Labelers:
